Mojave Brands Inc

PINK:HHPHF USA Drug Manufacturers - Specialty & Generic
Market Cap
$1.79 Million
Market Cap Rank
#42459 Global
#13720 in USA
Share Price
$0.18
Change (1 day)
+0.00%
52-Week Range
$0.18 - $0.18
All Time High
$1.05
About

Mojave Brands Inc. does not have significant operations. Previously, it was engaged in the manufacturing, processing, and sale of cannabis extracts. The company was formerly known as Mojave Jane Brands Inc. and changed its name to Mojave Brands Inc. in March 2020. Mojave Brands Inc. was incorporated in 2010 and is based in Vancouver, Canada. As of December 13, 2024, Mojave Brands Inc. operates as… Read more

Mojave Brands Inc (HHPHF) - Net Assets

Latest net assets as of November 2024: $-350.20K USD

Based on the latest financial reports, Mojave Brands Inc (HHPHF) has net assets worth $-350.20K USD as of November 2024.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($353.29K) and total liabilities ($703.49K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $-350.20K
% of Total Assets -99.13%
Annual Growth Rate 1.11%
5-Year Change -87.3%
10-Year Change N/A
Growth Volatility 181.25

Mojave Brands Inc - Net Assets Trend (2014–2023)

This chart illustrates how Mojave Brands Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Mojave Brands Inc (2014–2023)

The table below shows the annual net assets of Mojave Brands Inc from 2014 to 2023.

Year Net Assets Change
2023-08-31 $635.28K -9.78%
2022-08-31 $704.14K +10.54%
2021-08-31 $637.02K +281.10%
2020-08-31 $167.15K -96.66%
2019-08-31 $5.00 Million -86.73%
2018-08-31 $37.68 Million +361.23%
2017-08-31 $8.17 Million +3749.58%
2016-08-31 $-223.87K -9.19%
2015-08-31 $-205.03K -135.64%
2014-08-31 $575.25K --

Equity Component Analysis

This analysis shows how different components contribute to Mojave Brands Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 5693559100.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (August 2023)

Component Amount Percentage
Common Stock $55.94 Million 8805.25%
Other Comprehensive Income $7.02 Million 1105.12%
Total Equity $635.28K 100.00%

Mojave Brands Inc Competitors by Market Cap

The table below lists competitors of Mojave Brands Inc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Mojave Brands Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2022 to 2023, total equity changed from 704,136 to 635,278, a change of -68,858 (-9.8%).
  • Net loss of 68,858 reduced equity.

Equity Change Factors (2022 to 2023)

Factor Impact Contribution
Net Income $-68.86K -10.84%
Total Change $- -9.78%

Book Value vs Market Value Analysis

This analysis compares Mojave Brands Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.73x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has increased from 0.02x to 0.73x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-08-31 $7.62 $0.18 x
2018-08-31 $9.93 $0.18 x
2019-08-31 $1.17 $0.18 x
2020-08-31 $0.14 $0.18 x
2021-08-31 $0.48 $0.18 x
2022-08-31 $0.27 $0.18 x
2023-08-31 $0.25 $0.18 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Mojave Brands Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -10.84%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.00%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 1.09x
  • Recent ROE (-10.84%) is above the historical average (-588.54%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2014 -1123.87% -45754.01% 0.01x 1.82x $-6.52 Million
2015 0.00% -23587.61% 0.04x 0.00x $-759.77K
2016 0.00% 0.00% 0.00x 0.00x $-146.46K
2017 -9.82% 0.00% 0.00x 1.23x $-1.62 Million
2018 -24.32% -17551.12% 0.00x 1.11x $-12.93 Million
2019 -790.39% -19275.12% 0.03x 1.31x $-40.03 Million
2020 -3906.07% 0.00% 0.00x 3.96x $-6.55 Million
2021 -29.61% 0.00% 0.00x 1.48x $-252.29K
2022 9.53% 0.00% 0.00x 1.26x $-3.29K
2023 -10.84% 0.00% 0.00x 1.09x $-132.39K

Industry Comparison

This section compares Mojave Brands Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $548,450,613
  • Average return on equity (ROE) among peers: -450.37%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Mojave Brands Inc (HHPHF) $-350.20K -1123.87% N/A $45.90K
Ascend Wellness Holdings Inc (AAWH) $142.87 Million -33.75% 5.44x $48.90 Million
AB Science S.A (ABSCF) $10.73 Million -252.65% 3.71x $39.89 Million
Alterola Biotech Inc (ABTI) $4.85K -2005.32% 0.49x $603.58K
Aurora Cannabis Inc (ACB) $2.04 Billion -34.08% 0.34x $199.15 Million
Acreage Holdings Inc (ACRDF) $204.27 Million -30.85% 1.41x $13.48K
Acura Pharmaceuticals Inc (ACUR) $7.90 Million -63.15% 1.15x $13.20K
Agra Ventures Ltd. (AGFAF) $1.51 Million -44.22% 0.06x $298.23K
Allergy Therapeutics plc (AGYTF) $2.07 Million -2084.75% 31.32x $25.30 Million
Aida Pharmaceuticals Inc (AIDA) $6.67 Million 24.51% 2.78x $1.80
Adcock Ingram Holdings Limited (AIHLF) $3.07 Billion 20.55% 0.55x $85.61 Million